Is omicron leading us closer to herd immunity against COVID-19? Experts weigh in

Experts say it's not likely that the highly transmissible omicron variant — or any other variant — will lead us closer to herd immunity against COVID-19.

What is bebtelovimab? US authorizes new antibody drug to fight omicron

U.S. health regulators on Friday authorized bebtelovimab, a new antibody drug that targets the omicron variant, a key step in restocking the nation's arsenal against the latest version of COVID-19.

US COVID-19 death toll hits 900,000, sped by omicron

Propelled in part by the wildly contagious omicron variant, the U.S. death toll from COVID-19 hit 900,000 on Friday, less than two months after eclipsing 800,000.

COVID falling in 49 of 50 states as deaths near 900,000

With the brutal omicron wave rapidly loosening its grip, new cases of COVID-19 in the U.S. are falling in 49 of 50 states, even as the nation's death toll closes in on another bleak round number: 900,000.

Omicron peak may be on the horizon, but people should still take precautions

Medical experts caution the new data is positive news, but we still may continue to see very high numbers of case counts and hospitalizations even as the curve heads down.

Omicron variant less likely to require hospitalization, studies show

Scientists stress that even if the findings of these early studies hold up, any reductions in severity need to be weighed against the fact omicron spreads much faster than delta and is more able to evade vaccines.

COVID-19 surge: Here’s what’s canceled or closing across the US

As the omicron variant continues to spread across the country, many events are getting canceled and businesses are closing.

Omicron variant appearing milder than delta, South African doctors say

In the two weeks since omicron first was reported in Southern Africa, other doctors have shared similar stories. All caution that it will take many more weeks to collect enough data to be sure, their observations and the early evidence offer some clues.

Omicron variant: Pfizer running ‘neutralization tests’ with its COVID-19 vaccine

Companies Pfizer and BioNTech are currently running tests in response to the rapidly spreading omicron variant with data likely available in the coming weeks.

Study suggests past COVID-19 infection may not fend off omicron variant

A research group has been tracking reinfections in South Africa and reported a jump with the arrival of omicron that they hadn't seen when two previous variants, including the extra-contagious delta variant, moved through the country.